<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38370106</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1937-8688</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>Suppl 2</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>The Pan African medical journal</Title><ISOAbbreviation>Pan Afr Med J</ISOAbbreviation></Journal><ArticleTitle>Providing information for decision-making in the Nigerian Polio Eradication Program, 2016-2020.</ArticleTitle><Pagination><StartPage>11</StartPage><MedlinePgn>11</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">11</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.supp.2023.45.2.39489</ELocationID><Abstract><AbstractText>Nigeria made a coordinated effort to be certified by the World Health Organization's African Region for interrupting endemic transmission of wild poliovirus type-1 (WPV1) in August 2020 as a response to the resurgence of WPV1 cases in August 2016 after going two years without a case. The NEOC Data Working Group (DWG) was instrumental in providing quality and timely surveillance and campaign information for decision-making in order to interrupt WPV1 transmission and provide data toward documentation of its elimination for regional certification. The polio pre-campaign dashboard was used to assess the level of preparedness for Oral Poliovirus Vaccine (OPV) polio supplementary immunization activities (SIA) at three weeks, two weeks, one week, and three days to the start of each campaign implemented during 2016-2020. The administrative tally sheet, independent monitoring survey, and Lot Quality Assurance Sampling (LQAS) survey data collected and shared from the implementation level were analyzed by the EOC DWG to provide information by person, place, and time. Using a 90% threshold in LQAS surveys defining quality SIAs, the proportion of Local Government Areas (LGAs) in Nigeria's states in which post-SIA LQAS surveys were conducted that met this threshold were assessed over time. The highest level of preparedness attained by 3 days to a polio campaign during August 2016-February 2020 was 95% and the lowest attained was 77%. The admin, independent monitoring, and LQAS data analysis results were given to EOC working groups for assessing the performance and quality of each campaign. Twenty-twenty five percent of LGAs that failed LQAS were identified for repeat vaccination. Further, acute flaccid paralysis and environmental surveillance data and laboratory results were analyzed and shared with NEOC and partners. The government and partners used the information generated by the Data Working Group to take evidence-based action including determining the scope of the polio campaign, intensification of surveillance and routine immunization activities, and special intervention activities. On average, 12% of the 774 LGAs were identified as polio high risk LGAs for intervention using selected surveillance, routine immunization (RI), SIAs, and other relevant data sets. National Emergency Operation Centre Data Working Group provided quality and timely information that supported decision-making processes for the polio program in Nigeria. The quality and timely information enabled the NEOC to make evidence-based and timely decisions that contributed to gap identification and decision-making.</AbstractText><CopyrightInformation>Â©Tesfaye Erbeto et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Erbeto</LastName><ForeName>Tesfaye</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bammeke</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aregay</LastName><ForeName>Aron</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamran</LastName><ForeName>Zabihullah</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>United Nations Children's Fund Nigeria Country Office, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usifoh</LastName><ForeName>Nnamdi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>African Field Epidemiology Network, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamu</LastName><ForeName>Usman</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>National Primary Healthcare Development Agency, Abuja, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Emergency Operation Centre, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omotayo</LastName><ForeName>Bolu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centers for Disease Control and Prevention, Atlanta, Georgia, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braka</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damisa</LastName><ForeName>Eunice</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>National Primary Healthcare Development Agency, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazadi</LastName><ForeName>Walter</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shuaib</LastName><ForeName>Faisal</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Primary Healthcare Development Agency, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Pan Afr Med J</MedlineTA><NlmUniqueID>101517926</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055810" MajorTopicYN="N">Lot Quality Assurance Sampling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Vaccination campaign</Keyword><Keyword MajorTopicYN="N">dashboard</Keyword><Keyword MajorTopicYN="N">decision-making</Keyword><Keyword MajorTopicYN="N">information</Keyword><Keyword MajorTopicYN="N">local government areas</Keyword><Keyword MajorTopicYN="N">monitoring</Keyword><Keyword MajorTopicYN="N">polio</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>20</Day><Hour>11</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>4</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38370106</ArticleId><ArticleId IdType="pmc">PMC10874091</ArticleId><ArticleId IdType="doi">10.11604/pamj.supp.2023.45.2.39489</ArticleId><ArticleId IdType="pii">PAMJ-45-11</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . PRESS RELEASE - WHO and UNICEF congratulate Nigeria on ending wild poliovirus; call for strengthening of routine immunisation. August 25 2020, Accessed August 9 2021.</Citation></Reference><Reference><Citation>National Primary Health Care Development Agency National polio eradication emergency plan. 2021.</Citation></Reference><Reference><Citation>National Primary Health Care Development Agency 2014 Nigeria polio eradication emergency plan. December 2013, Accessed August 9 2021.</Citation></Reference><Reference><Citation>Ntsama B, Bwaka A, Katsande R, Obiang RM, Oyaole DR, Mkanda P, et al. Polio Data Quality Improvement in the African Region. J Immunol Sci. 2021 Apr 16;(Spec Issue(2)):1105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7610762</ArticleId><ArticleId IdType="pubmed">33997861</ArticleId></ArticleIdList></Reference><Reference><Citation>Azemi N, Zaidi H, Hussin N. Information Quality in Organization for Better Decision Making. Int J Acad Res Bus Soc Sci. 2018 Jan;7(12):429â37.</Citation></Reference><Reference><Citation>Tom-Aba D, Olaleye A, Olayinka AT, Nguku P, Waziri N, Adewuyi P, et al. Innovative Technological Approach to Ebola Virus Disease Outbreak Response in Nigeria Using the Open Data Kit and Form Hub Technology. PLoS One. 2015 Jun 26;10(6):e0131000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4482726</ArticleId><ArticleId IdType="pubmed">26115402</ArticleId></ArticleIdList></Reference><Reference><Citation>Oteri AJ, Adamu U, Dieng B, Bawa S, Terna N, Nsubuga P, et al. Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up. Vaccine. 2021 Nov 17;39(Suppl 3):C3âC11.</Citation><ArticleIdList><ArticleId IdType="pubmed">33962837</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . 2016. Planning and implementing high-quality supplementary immunization activities for injectable vaccines using an example of measles and rubella vaccines: field guide.</Citation></Reference><Reference><Citation>Ado JM, Etsano A, Shuaib F, Damisa E, Mkanda P, Gasasira A, et al. Mahoney, Progress Toward Poliomyelitis Eradication in Nigeria. J Infect Dis. 2014 Nov 1;210(Suppl 1):S40â9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11177795</ArticleId><ArticleId IdType="pubmed">25316862</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Global Guidelines Independent Monitoring of Polio Supplementary Immunization Activities (SIA) 2015.</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative . Assessing Vaccination Coverage Levels Using Clustered Lot Quality Assurance Sampling: Field Guide. April 27, 2012, Accessed August 9, 2021.</Citation></Reference><Reference><Citation>Brown AE, Okayasu H, Nzioki MM, Wadood MZ, Chabot-Couture G, Quddus A, et al. Lot Quality Assurance Sampling to Monitor Supplemental Immunization Activity Quality: An Essential Tool for Improving Performance in Polio Endemic Countries. J Infect Dis. 2014 Nov 1;210(Suppl 1):S333â40.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316852</ArticleId></ArticleIdList></Reference><Reference><Citation>Poy A, Minkoulou E, Shaba K, Yahaya A, Gaturuku P, Dadja L, et al. Polio Eradication Initiative contribution in strengthening immunization and integrated disease surveillance data management in WHO African region, 2014. Vaccine. 2016 Oct 10;34(43):5181â5186.</Citation><ArticleIdList><ArticleId IdType="pubmed">27389171</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>